Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy

Johanna Buchroithner; Josef Pichler; Christine Marosi; Georg Widhalm; Marcel Seiz-Rosenhagen; Martha Novosielski; Stefan Oberndorfer; Reinhard Ruckser; Karl Rössler; Amedeo Azizi; Gord von Campe; Karin Bordihn; Thomas Felzmann

doi:10.5414/CPXCES13EA02

Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy

Johanna Buchroithner
, Josef Pichler
, Christine Marosi
, Georg Widhalm
, Marcel Seiz-Rosenhagen
, Martha Novosielski
, Stefan Oberndorfer
, Reinhard Ruckser
, Karl Rössler
, Amedeo Azizi
, Gord von Campe
, Karin Bordihn
, Thomas Felzmann

Division of Neurology (University Hospital St. Pölten)

Research output: Journal article (peer-reviewed) › Journal article

19 Citations (Scopus)

Original language	English
Pages (from-to)	76-77
Number of pages	2
Journal	International Journal of Clinical Pharmacology and Therapeutics
Volume	52
Issue number	1
DOIs	https://doi.org/10.5414/CPXCES13EA02
Publication status	Published - Jan 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Brain Neoplasms/therapy
Dendritic Cells/immunology
Glioblastoma/therapy
Humans
Immunotherapy
Vascular Endothelial Growth Factor A/antagonists & inhibitors

Access to Document

10.5414/CPXCES13EA02

Cite this

Buchroithner, J., Pichler, J., Marosi, C., Widhalm, G., Seiz-Rosenhagen, M., Novosielski, M., Oberndorfer, S., Ruckser, R., Rössler, K., Azizi, A., von Campe, G., Bordihn, K., & Felzmann, T. (2014). Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy. International Journal of Clinical Pharmacology and Therapeutics, 52(1), 76-77. https://doi.org/10.5414/CPXCES13EA02

@article{fcfa96f4c9fc409b9a9a47b5d050f017,

title = "Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy",

keywords = "Brain Neoplasms/therapy, Dendritic Cells/immunology, Glioblastoma/therapy, Humans, Immunotherapy, Vascular Endothelial Growth Factor A/antagonists \& inhibitors",

author = "Johanna Buchroithner and Josef Pichler and Christine Marosi and Georg Widhalm and Marcel Seiz-Rosenhagen and Martha Novosielski and Stefan Oberndorfer and Reinhard Ruckser and Karl R{\"o}ssler and Amedeo Azizi and \{von Campe\}, Gord and Karin Bordihn and Thomas Felzmann",

year = "2014",

month = jan,

doi = "10.5414/CPXCES13EA02",

language = "English",

volume = "52",

pages = "76--77",

journal = "International Journal of Clinical Pharmacology and Therapeutics",

issn = "0946-1965",

publisher = "Dustri-Verlag Dr. Karl Feistle",

number = "1",

}

Buchroithner, J, Pichler, J, Marosi, C, Widhalm, G, Seiz-Rosenhagen, M, Novosielski, M, Oberndorfer, S, Ruckser, R, Rössler, K, Azizi, A, von Campe, G, Bordihn, K & Felzmann, T 2014, 'Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy', International Journal of Clinical Pharmacology and Therapeutics, vol. 52, no. 1, pp. 76-77. https://doi.org/10.5414/CPXCES13EA02

TY - JOUR

T1 - Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy

AU - Buchroithner, Johanna

AU - Pichler, Josef

AU - Marosi, Christine

AU - Widhalm, Georg

AU - Seiz-Rosenhagen, Marcel

AU - Novosielski, Martha

AU - Oberndorfer, Stefan

AU - Ruckser, Reinhard

AU - Rössler, Karl

AU - Azizi, Amedeo

AU - von Campe, Gord

AU - Bordihn, Karin

AU - Felzmann, Thomas

PY - 2014/1

Y1 - 2014/1

KW - Brain Neoplasms/therapy

KW - Dendritic Cells/immunology

KW - Glioblastoma/therapy

KW - Humans

KW - Immunotherapy

KW - Vascular Endothelial Growth Factor A/antagonists & inhibitors

UR - https://www.scopus.com/pages/publications/84897991927

U2 - 10.5414/CPXCES13EA02

DO - 10.5414/CPXCES13EA02

M3 - Journal article

C2 - 24321210

SN - 0946-1965

VL - 52

SP - 76

EP - 77

JO - International Journal of Clinical Pharmacology and Therapeutics

JF - International Journal of Clinical Pharmacology and Therapeutics

IS - 1

ER -

Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy

UN SDGs

Keywords

Access to Document

Other files and links

Cite this